References
- Ando H. Y., Ho N. F. N., Higuchi W. I. Skin as an active metabolizing barrier 1: Theoretical analysis of topical bioavailability. Journal of Pharmaceutical Sciences 1977; 66(11)1525
- Birnbaum J. E., Chan P. S., Cervoni P., Dessy F., Van Humbeeck L. Cutaneous erythema and blood pressure lowering effects of topically applied 16-vinyl prostaglandins. Prostaglandins 1982a; 23(2)185
- Birnbaum J. E., Cervoni P., Chan P. S., Chen S. M., Floyd M. B., Grudzinskas C. V., Weiss M. J., Dessy F. Prostaglandins and cogeners. (16S)-(pT)-15-deoxy-16-hydroxy-16-vinyl prostaglandin E2, an orally and transdermally active hypotensive agent of prolonged duration. Journal of Medicinal Chemistry 1982b; 25: 492
- Guy R. H., Hadgraft J. Skin Metabolism: Theoretical. Percutaneous Absorption, R. L. Bronaugh, H. I. Maibach. Marcel Dekker Inc. Publisher, New York 1985; 57
- Kao J., Patterson F. K., Hall J. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: An in vitro study with benz(a)pyrene and testosterone. Toxicology and Applied Pharmacology 1985; 81: 502
- Nicoľau G., Batra V. K., Gordon S., Tonelli A., McWilliams W. Transdermal absorption of DHV-PGE2 prostaglandin in the rat. Vth International Conference on Prostaglandins. 1982; 506, Abstracts
- Nicolau G., Dahlin D., Kohlbrenner M., Chan P. S., Ronsberg M. A., Saunders T. K., Yacobi A., Cervoni P. Skin metabolism and transdermal absorption of viprostol, a synthetic PGE2, in the rat; effect of vehicle. Drug Metabolism and Disposition. 1986a, (submitted)
- Nicolau G., Cosulich D. B., Tonelli A., Chen S. M., Pruzinsky M. S., Blum D. Metabolism of viprostol–A synthetic vasodilator PGE2 analog. Prostaglandins 1986b; 31: 811
- Scheuplein R. J., Bronaugh R. L. Percutaneous absorption. Biochemistry and Physiology of the Skin, L. A. Goldsmith. Oxford Univ. Press, New York 1983; Vol. 2: 1255–1295
- Yacobi A., Baughman R. A., Cosulich D. B., Nicolau G. Method for determination of first-pass metabolism in human skin. Journal of Pharmaceutical Sciences 1985; 73(10)1499